Intranasal LHRH agonist combined periodically with a progestogen for contraception.
Lemay
A
A
Hôpital St-François d'Assise, Département d'obstétrique-gynécologie, Université Laval, Quebec, Canada.
D000281:Administration, Intranasal; D002064:Buserelin / Q000008:administration & dosage* / Q000627:therapeutic use; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D004341:Drug Evaluation; D004715:Endometriosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage* / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000188:drug therapy
D003271:Contraceptive Agents, Female; D008525:Medroxyprogesterone; D002064:Buserelin